Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$2.2M
-2.4% from 2023
Prescriptions
217
$10,002.12 per claim
Patients
27
17 prescribers
Total spending, 2024
$2.2M
$80,387.41 per patient
Medicare prescription drug plans paid $2.2M for Empliciti in 2024, for 217 prescriptions and refills to 27 patients (down 2.4% from 2023). The average cost per claim was $10,002.12.
California had the highest Medicare cost for Empliciti in 2024: $1.1M for 86 claims, followed by New Jersey ($458K).
James R Berenson, hematology-oncology in West Hollywood, CA, had the highest Medicare cost for Empliciti in 2024: 76 claims costing $891K.
Empliciti is made by Bristol-Myers Squibb Company (BMY), listed in the Medicare spending data as BMS Primarycare.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| James R Berenson West Hollywood, CA | Hematology-Oncology | 76 | Under 11 | $891K |
| Thomas R Blom Princeton, NJ | Hematology-Oncology | 38 | Under 11 | $303K |
| Tejvir Singh |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 28 | 277 | 43 | $3.0M |
| 2023 | 19 | 203 | 31 | $2.2M |
| 2024 | 17 | 217 | 27 | $2.2M |
Spending by manufacturer as listed in the spending data
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Internal Medicine |
| 20 |
| Under 11 |
| $152K |
| Alec S Goldenberg New York, NY | Hematology-Oncology | 36 | Under 11 | $93K |
| Manufacturer | Claims | Spending |
|---|---|---|
| BMS Primarycare BMY | 217 | $2.2M |